Results 131 to 140 of about 110,931 (189)

The Danish randomized trial of trifluridine-tipiracil and bevacizumab in metastatic colorectal cancer: final survival and <i>post hoc</i> neutropenia and quality-of-life analyses. [PDF]

ESMO Gastrointest Oncol
Kreiberg KB, Qvortrup C, Winther SB, Zitnjak D, Poulsen LØ, Yilmaz MN, Brink C, Tarpgaard LS, Pfeiffer P.   +8 more
europepmc   +1 more source

Trifluridine/tipiracil with or without bevacizumab in microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: A retrospective observational study. [PDF]

Ther Adv Med Oncol
Hasegawa H, Inamoto R, Sugiyama K, Izawa N, Mitani S, Kawakami T, Yuki S, Hirano H, Mishima S, Hamano T, Masuishi T.   +10 more
europepmc   +1 more source

Bevacizumab plus nab-paclitaxel and platinum as second-line therapy for driver-gene-negative non-squamous non-small cell lung cancer after immunochemotherapy: A prospective single-arm single-centre study. [PDF]

Clin Transl Med
Lin Y, Yu Y, Hu Z, Wei C, Wang Z, Zhang Y, Wu Z, Yu B, Zhao X, Yu H, Wu X, Wang H, Wang J.   +12 more
europepmc   +1 more source

Artificial Intelligence-Enabled Analysis of WNT Pathway Dysregulation in Bevacizumab-Treated Early-Onset Colorectal Cancer. [PDF]

Int J Mol Sci
Ruiz-Garcia E, Waldrup B, Carranza FG, Manjarrez S, Fernandez-Figueroa EA, Velazquez-Villarreal E.   +5 more
europepmc   +1 more source

Serplulimab combined with bevacizumab and chemotherapy as first-line treatment for recurrent or metastatic cervical cancer (ASTRUM-CC01): a phase II trial. [PDF]

Front Immunol
Liu H, Wang D, Tang J, Wang C, Li X, Lou G, Zhang G.   +6 more
europepmc   +1 more source

Impact of Bevacizumab Relative Dose Intensity and Treatment-Induced Proteinuria on the Efficacy of Trifluridine/Tipiracil Plus Bevacizumab in Metastatic Colorectal Cancer. [PDF]

Cancers (Basel)
Tsukida T, Shibutani M, Nakatani S, Tanda H, Seki Y, Kasashima H, Emoto M, Maeda K.   +7 more
europepmc   +1 more source

Cost-effectiveness analysis of combined immunotherapy regimens for non-squamous non-small lung cancer after tyrosine kinase inhibitors resistance. [PDF]

Front Public Health
Teng M, Yang B, Zhang R, Qin F, Ji J.
europepmc   +1 more source

Maintenance therapy in gynecologic malignancies: Current and future state. [PDF]

Cancer
Widick PC, Wright AA, Liu JF.
europepmc   +1 more source

Complete Remission of Erythrodermic Psoriasis After Bevacizumab Administration for Ovarian Serous Adenocarcinoma: A Case Report. [PDF]

Clin Case Rep
Wang N, Li L, Zhang Y.
europepmc   +1 more source